Employees: NN (None)Legal category: 5785Size: PMECreation date: 2001-10-04 (24 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT MARTIN (97150), Guadeloupe
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DU HOWELL CENTER : revenue, balance sheet and financial ratios
PHARMACIE DU HOWELL CENTER is a French company
founded 24 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT MARTIN (97150),
this company of category PME
shows in 2025 a net income positive of 274 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DU HOWELL CENTER (SIREN 439992876)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
274 006 €
545 317 €
292 407 €
581 434 €
-264 913 €
36 837 €
2 040 €
436 193 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DU HOWELL CENTER generates positive net income of 274 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 436 k€ -> 274 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
274 006 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 65%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 51%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
65.227%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
51.498%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DU HOWELL CENTER
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
193.257
311.545
360.457
930.027
230.214
151.919
85.39
65.227
Financial autonomy
25.899
18.142
17.811
7.355
24.788
31.199
45.672
51.498
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
65.232025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average-16 pts over 3 years
In 2025, the debt ratio of PHARMACIE DU HOWELL CENTER (65.23) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
51.5%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average+19 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DU HOWELL CENTER (51.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 221.51. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
221.511
Liquidity indicators evolution PHARMACIE DU HOWELL CENTER
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
137.523
76.798
104.873
90.645
186.668
143.186
237.085
221.511
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
221.512025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good+34 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DU HOWELL CENTER (221.51) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DU HOWELL CENTER in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DU HOWELL CENTER is estimated at
4 352 617 €
(range 2 953 707€ - 6 829 856€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2953k€4352k€6829k€
4 352 617 €Range: 2 953 707€ - 6 829 856€
NAF 5 année 2025
Valuation method used
Net Income Multiple
274 006 €
×
15.9x
=4 352 618 €
Range: 2 953 707€ - 6 829 857€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DU HOWELL CENTER with other companies in the same sector:
Frequently asked questions about PHARMACIE DU HOWELL CENTER
What is the revenue of PHARMACIE DU HOWELL CENTER ?
The revenue of PHARMACIE DU HOWELL CENTER is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DU HOWELL CENTER profitable?
Yes, PHARMACIE DU HOWELL CENTER generated a net profit of 274 k€ in 2025.
Where is the headquarters of PHARMACIE DU HOWELL CENTER ?
The headquarters of PHARMACIE DU HOWELL CENTER is located in SAINT MARTIN (97150), in the department Guadeloupe.
Where to find the tax return of PHARMACIE DU HOWELL CENTER ?
The tax return of PHARMACIE DU HOWELL CENTER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DU HOWELL CENTER operate?
PHARMACIE DU HOWELL CENTER operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart